THE REGIONAL DISEASE SURVEILLANCE SYSTEMS ENHANCEMENT (REDISSE) IN WEST AFRICA PROJECT IMPLEMENTED BY WEST AFRICAN HEALTH ORGANISATION (WAHO) ANNUAL REPORT AND FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2022 West African Health Organization (WAHO) The Regional Disease Surveillance Systems Enhancement (REDISSE) In West Africa Project Year ended 31 December 2022 CONTENTS PAGE General Information 1-2 Report of the Project Management Team 3 Independent Auditor’s Report on Financial Statements 4-6 Financial Statements: - Statement of Resources and Uses of Funds 7 - Statement of Assets and Liabilities 8 - Notes to the Financial Statements 9 – 12 Independent Auditor’s Report on Designated Account 13-15 Designated Account Statement 16 - Notes to the Designated Account Statement 17 Annexes: Annex 1: Reconciliation of amount received by REDISSE and amount disbursed by World Bank Annex 2: Schedule of Fixed Assets Register West African Health Organization (WAHO) The Regional Disease Surveillance Systems Enhancement (REDISSE) in West Africa Project Year ended 31 December 2022 GENERAL INFORMATION Project Management Team Prof. Stanley Okolo Director General (Contract ended on 02 August 2022) Dr Aissi Melchoir Athanase Joel Codjovi Director General (Effective 02 August 2022) Mr. Kevin Davidson Ag. Director of Administration and Finance (Contract ended on 31 July 2022) Mr. Akpene Dzikum Ag. Director of Administration and Finance (From 01 August 2022 to 28 April 2023) Mr. Aruna Fallah Ag. Director of Administration and Finance (Effective 15 May 2023) Mr. Sani Ali Director of Planning, & Health Information Dr Olusegun Moses Adeoye Ag. Project Management Unit Coordinator Dr Malik Coulibaly Project Office, REDISSE Dr Sayi Dona Alain Monitoring and Evaluation Specialist Mr. Harouna Dabre Financial Management Specialist Mr. Maurice Adjovi Procurement Specialist Mr. Sylvanus Azumah Illedi Project Accountant Ms. Tosin Adesina Monitoring & Evaluation Assistant Mr. Philip Abugri Translator Revisor Independent auditor PricewaterhouseCoopers Chartered Accountants PwC Tower A4 Rangoon Lane, Cantonments City PMB CT 42 Cantonments Accra Registered office West Africa Health Organisation (WAHO) Avenue Ouezzin Coulibaly 01 BP 153, Bobo-Dioulasso Burkina Faso Banker Ecobank SA Ouagadougou, Burkina Faso 1 West African Health Organization (WAHO) The Regional Disease Surveillance Systems Enhancement (REDISSE) in West Africa Project Year ended 31 December 2022 GENERAL INFORMATION (CONTINUED) PROJECT BACKGROUND The Regional Disease Surveillance Systems Enhancement Project in West Africa (REDISSE) is a project funded by the World Bank, and the governments of Canada and China, and implemented by the West Africa Health Organisation (WAHO). The project seeks to strengthen national and regional cross-sectoral capacity for collaborative disease surveillance and epidemic preparedness in West Africa. The project seeks to achieve this by addressing the weaknesses in human and animal health systems which impede surveillance and effective response to diseases and in the case of emergencies, provide an effective immediate response. The project which commenced in 2016 has been implemented in phases and is expected to end in August 2023. Phase 1 started in 2016 covering Guinea, Sierra Leone, and Senegal. Phase 2 begun in 2017 and covered Togo, Guinea-Bissau, Nigeria and Liberia. Phase 3 preparations commenced in late 2017 and currently covers Benin, Burkina Faso, Mali, Niger, and Mauritania. ECOWAS member countries expected to join before the end of the project include Cape Verde, Ghana, Côte d'Ivoire, and The Gambia. Contributions to the Project • US$ 400M - World Bank (IDA) • US$ 341M - MDTF Canada • US$ 2M - China • US$ 8.9M - DSWRA TF Under the project, WAHO has a budget allocation of US$20 million from the IDA funds and US$8.9 million from the Disease Surveillance and Response in West Africa Multi-Donor (DSWRA) Trust Fund. Objectives of the Project • To strengthen national and regional cross-sectoral capacity for collaborative disease surveillance and epidemic preparedness in West Africa; and • In the event of an eligible crisis or emergency, to provide immediate and effective response to the said eligible crisis or emergency. Components of the Project • Component 1: Surveillance and health information • Component 2: Strengthening laboratory capacity building • Component 3: Emergency Preparedness and Response • Component 4: Human resource management for effective disease surveillance and outbreak preparedness • Component 5: Institutional Capacity Building, Project Management, Coordination and Advocacy 2 West AjHcan Health Orqanizatioti (WAHO) The Regional Disease Surveillance Systems Enhancement (REDISSE) in West Africa Project Year ended 31 December 2022 REPORT OF THE PROJECT MANAGEMENT TEAM The Project Management Team presents herewith the audited financial statements for the Regional Disease Surveillance Systems Enhancement in West Africa Project (REDISSE) for the year ended 31 December 2022. Statement of the Project Management Team's responsibilities The Project Management Team is responsible for the preparation of the financial statements for the period, which have been prepared in ail material respects in accordance with the accounting policies described in note 1 to the financial statement. In preparing these financial statements, the Project Management Team has selected suitable accounting policies and then applied them consistently, made judgements that are reasonable and prudent and followed the requirements of the project financing agreement IDA D1310 between World Bank and WAHO. The Project Management Team is responsible for ensuring that the Project keeps proper accounting records that disclose with reasonable accuracy at any time the financial performance of the Project. The Project Management Team is also responsible for safeguarding the assets of the Project and taking reasonable steps for the prevention and detection of fraud and other irregularities. Principal activities of the Project The principal activities under the Project are stated on page 2 of this report. Financial Results The Statement of Resources and Uses of funds on page 7 shows net increase in project funds during the year. Independent Auditor PwC has expressed willingness to continue in office as auditors for the project in accordance with the agreed contract dated 26 August 2021. BV OROER OF THE PROJECT MANAGEMENT TEAM Oirector General inistration and Finance 3 INDEPENDENT AUDITOR’S REPORT TO THE MEMBERS OF PROJECT MANAGEMENT TEAM, WEST AFRICAN HEALTH ORGANISATION REPORT ON THE AUDIT OF THE FINANCIAL STATEMENTS Our opinion In our opinion, the accompanying financial statements of the Regional Disease Surveillance Systems Enhancement in West Africa Project (REDISSE) (the Project) for the year ended 31 December 2022 are prepared, in all material respects, in accordance with the financial reporting provisions of the project financing agreement IDA D1310 between West African Health Organisation (WAHO) and World Bank. What we have audited We have audited the financial statements of the Regional Disease Surveillance Systems Enhancement in West Africa Project (REDISSE) for the year ended 31 December 2022. The financial statements comprise: • the statement of resources and uses of funds for the year ended 31 December 2022; • the statement of assets and liabilities as at 31 December 2022; and • the notes to the financial statements, which include a summary of significant accounting policies. Basis for opinion We conducted our audit in accordance with International Standards on Auditing (ISAs). Our responsibilities under those standards are further described in the Auditor’s responsibilities for the audit of the financial statements section of our report. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion. Independence We are independent of the REDISSE project, the West African Health Organization (WAHO) and the World Bank in accordance with the International Code of Ethics for Professional Accountants (including International Independence Standards) (the Code) issued by the International Ethics Standards Board for Accountants. We have fulfilled our other ethical responsibilities in accordance with the Code. Emphasis of matter – Basis of accounting and restriction on distribution and use We draw attention to note 1 to the financial statements, which describes the basis of accounting. The financial statements are prepared in accordance with the financial reporting provisions of the Project Financing Agreement IDA D1310. As a result, the financial statements may not be suitable for another purpose. Our report is intended solely for the West African Health Organisation and the World Bank and should not be distributed to or used by parties other than the West African Health Organisation and World Bank. Our opinion is not modified in respect of this matter. 4 INDEPENDENT AUDITOR’S REPORT TO THE MEMBERS OF PROJECT MANAGEMENT TEAM, WEST AFRICAN HEALTH ORGANISATION REPORT ON THE AUDIT OF THE FINANCIAL STATEMENTS (CONTINUED) Other Information The Project Management Team is responsible for the other information. The other information comprises the General Information and the Report of the Project Management Team but does not include the financial statements and our auditor’s report thereon. Our opinion on the financial statements does not cover the other information and we do not express any form of assurance conclusion thereon. In connection with our audit of the financial statements, our responsibility is to read the other information identified above and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit, or otherwise appears to be materially misstated. If, based on the work we have performed on the other information, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard. Responsibilities of management and those charged with governance for the financial statements Management is responsible for the preparation of the financial statements in accordance with the financial reporting provisions of the Project Financing Agreement IDA 1310 and for such internal control as management determines is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. In preparing the financial statements, management is responsible for assessing the Project’s ability to continue as a going concern. Under the terms of the financing agreement the project will end on 31 August 2023. Those charged with governance are responsible for overseeing the Project’s financial reporting process. Auditor’s responsibilities for the audit of the financial statements Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements. As part of an audit in accordance with ISAs, we exercise professional judgement and maintain professional scepticism throughout the audit. We also: 5 INDEPENDENT AUDITOR’S REPORT TO THE MEMBERS OF PROJECT MANAGEMENT TEAM, WEST AFRICAN HEALTH ORGANISATION REPORT ON THE AUDIT OF THE FINANCIAL STATEMENTS (CONTINUED) Auditor’s responsibilities for the audit of the financial statements (continued) • Identify and assess the risks of material misstatement of the financial statements, whether due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control; • Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Project’s internal control; • Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and related disclosures made by management; and • Conclude on the appropriateness of management’s use of the going concern basis of accounting and, based on the audit evidence obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on the Project’s ability to continue as a going concern. If we conclude that a material uncertainty exists, we are required to draw attention in our auditor’s report to the related disclosures in the financial statements or, if such disclosures are inadequate, to modify our opinion. Our conclusions are based on the audit evidence obtained up to the date of our auditor’s report. However, future events or conditions may cause the Project’s to cease to continue as a going concern. We communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit and significant audit findings, including any significant deficiencies in internal control that we identify during our audit. The engagement partner on the audit resulting in this independent auditor’s report is Maxwell Darkwa ((ICAG/P/1143). PricewaterhouseCoopers (ICAG/F/2023/028) Chartered Accountants Accra, Ghana 19 June 2023 6 WestA.fricanHealth Orqanization. (WAHO) The Regional Disease Surveillance Systems Enhancement (REDISSE) in West Africa Project Financial Statements For the year ended 31 December 2022 STATEMENT OF RESOURCES AND USES OF FUNDS (Ali amounts are expressed in US dollars unless otherwise stated) Notes Year ended 31 Cumulative to Cumulative to Decem ber 2022 date 2021 RESOURCES US$ US$ US$ Balance as at 1 January 2022 635,143 Receipts from the World Bank 2 1,524,854 15,369,783 13,844,929 Disbursement to 3rd parties by the World Bank on behalf of REDISSE 3 2,210,147 13,395,519 11,185,372 Reimbursement - WAHO Prefinances 4 122,669 122,669 4,370.144 28.887.971 25,152,970 USES Expenses per project components 5 4,260,819 27,786,110 23,525,291 Disbursements to implementing partners 6 867,885 867,885 Foreign exchange losses 7 1,982 1,982 Expenses prefinanced by WAHO 8 122,669 122,669 Total Uses of Funds 412601819 2817781646 24,517,827 Net increase in project funds during the year 1091325 1091325 635143 The notes on pages 9 to12 are an integral part of these financial statements. The financi statements on pages 7 t012 were approved by the Project Management Team on .... June 2022 and signed on its behalf by: 7 West African Health Organization (WAHO) The Regional Disease Surveillance Systems Enhancement (REDISSE) in West Africa Project Financial Statements For the year ended 31 December 2022 STATEMENT OF ASSETS AND LIABILITIES (All amounts are expressed in US dollars unless otherwise stated) As at 31 December 2022 2021 Note Current assets Cash and cash equivalents 9 273,606 640,242 Accounts receivable 10 - 741 Total current assets 273,606 640,983 Current liabilities Accounts payable 11 164,281 5,840 Total current liabilities 164,281 5,840 Net assets 109,325 635,143 Represented by: Accumulated Fund 12 109,325 635,143 The notes on pages 9 to12 are an integral part of these financial statements. 8 West African Health Organization (WAHO) The Regional Disease Surveillance Systems Enhancement (REDISSE) in West Africa Project Financial Statements For the year ended 31 December 2022 NOTES (All amounts in the notes are expressed in US dollars unless otherwise stated) 1. Accounting policies The following are the significant accounting policies adopted in the preparation of these financial statements: (a) Basis of accounting The financial statements have been prepared in accordance with the requirements of the project financing agreement IDA D1310 between World Bank and WAHO. (b) Resources Receipts from the World Bank These are recognised as resources upon receipt of funds in the Project’s designated bank account. Disbursement to 3rd parties by the World Bank on behalf of REDISSE These are direct payments made to implementing partners by World Bank for project activities. Reimbursements – WAHO Prefinances These are reimbursements made by the World Bank, to WAHO’s general fund accounts for project activities prefinanced by WAHO. (c) Uses This comprises expenditure incurred under the five (5) components of the project. Uses of funds are recognised when payment is made for goods and services relating to project activities. (d) Fixed assets Fixed assets are expensed in the year of acquisition. (e) Foreign currency translation Transactions in foreign currencies (currencies other than the United States Dollar) are converted at the rate ruling at the date of the transaction. Current assets and liabilities denominated in foreign currencies are translated at the rate of exchange ruling at the balance sheet date. Gains or losses arising on foreign currency transactions are credited to or charged against recurrent expenditure in the period in which they arise. (f) Accounts payable This relates to amounts due to WAHO for prefinancing REDISSE project activities. (g) Commitments These are project expenses incurred and yet to be paid. 9 West African Health Organization (WAHO) The Regional Disease Surveillance Systems Enhancement (REDISSE) in West Africa Project Financial Statements For the year ended 31 December 2022 NOTES (CONTINUED) (All amounts are expressed in US dollars unless otherwise stated) 2. Receipts from the World Bank Year ended 31 December 2022 Funds received - 27th tranche 360,327 Funds received - 28th tranche 545,446 Funds received - 29th tranche 449,719 Funds received - 30th tranche 169,362 1,524,854 3. Disbursement to 3rd parties by the World Bank on behalf of REDISSE Year ended 31 December 2022 Disbursement to Centre for International Cooperation in 1,221,439 Health and Development (CCISD) Disbursement to Foundation Merieux 676,168 Disbursement to World Organisation for Animal Health 312,540 2,210,147 4. Reimbursement – WAHO Prefinances These are reimbursements to WAHO by World Bank for prefinancing the REDISSE project activities. 10 West African Health Organization (WAHO) The Regional Disease Surveillance Systems Enhancement (REDISSE) in West Africa Project Financial Statements For the year ended 31 December 2022 NOTES (CONTINUED) (All amounts are expressed in US dollars unless otherwise stated) Year ended 31 Cumulative to Cumulative to December 2022 date 2021 5. Expenses per project components Component 1: Surveillance and health information; 2,213,517 13,590,184 11,376,667 Component 2: Laboratory capacity building 48,979 812,742 763,763 Component 3: Emergency Preparedness and Response 653,138 6,017,924 5,364,786 Component 5: Institutional capacity strengthening, Project management, coordination and advocacy 1,345,185 7,365,260 6,020,075 4,260,819 27,786,110 23,525,291 6. Disbursements to implementing partners Disbursements to implementing partners - 867,885 867,885 7. Foreign exchange losses Losses on foreign exchange - 1,982 1,982 8. Expenses prefinanced by WAHO Prefinance from WAHO - 53,100 53,100 Prefinance from P/MTN - 19,693 19,693 Prefinance from MRH - 42,016 42,016 Prefinance from SWEDD - 7,860 7,860 - 122,669 122,669 11 West African Health Organization (WAHO) The Regional Disease Surveillance Systems Enhancement (REDISSE) in West Africa Project Financial Statements For the year ended 31 December 2022 NOTES (CONTINUED) (All amounts in the notes are expressed in US dollars unless otherwise stated) 9. Cash and cash equivalents Year ended 31 Year ended 31 December December 2022 2021 Cash at bank 273,606 640,242 10. Accounts receivable Prefinance to P/MTN - - Prefinance to WAHO - - Prefinance to SHRAY - 309 Prefinance to CAPS - 432 - 741 Receivables represent pre-financed expenditures by the REDISSE project on behalf of other WAHO projects. 11. Accounts payable 2022 2021 Prefinance from WAHO 164,281 5,840 Payables represents pre-financed project expenditures by WAHO on behalf of the REDISSE Project yet to be reimbursed as at 31 December 2022. 12. Accumulated fund 2022 2021 Balance as at 31 December 273,606 640,242 Add: Receivable from other WAHO projects - 741 Less : Prefinances from WAHO and other projects (164,281) - Less: Wrong credit in bank account - (5,840) Fund balance 109,325 635,143 13. Commitments Audit fees 14,198 22,149 This represents audit fees for the project for the year ended 31 December 2022. 12 INDEPENDENT AUDITOR’S REPORT TO THE MEMBERS OF PROJECT MANAGEMENT TEAM, WEST AFRICAN HEALTH ORGANISATION REPORT ON THE DESIGNATED ACCOUNTS STATEMENTS Our opinion In our opinion, the accompanying financial statements of the Regional Disease Surveillance Systems Enhancement in West Africa Project (REDISSE) (the Project) for the year ended 31 December 2022 are prepared, in all material respects, in accordance with the financial reporting provisions of IDA D1310 of the Project financing agreement between West African Health Organisation (WAHO) and World Bank. What we have audited We have audited the financial statements of the Regional Disease Surveillance Systems Enhancement in West Africa Project (REDISSE) for the year ended 31 December 2022. The financial statements comprise: • designated account statement for the year 31 December 2022; and • the notes to the financial statements, which include a summary of significant accounting policies. Basis for opinion We conducted our audit in accordance with International Standards on Auditing (ISAs). Our responsibilities under those standards are further described in the Auditor’s responsibilities for the audit of the financial statements section of our report. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion. Independence We are independent of the REDISSE project, the West African Health Organization (WAHO) and the World Bank in accordance with the International Code of Ethics for Professional Accountants (including International Independence Standards) (the Code) issued by the International Ethics Standards Board for Accountants. We have fulfilled our other ethical responsibilities in accordance with the Code. Emphasis of matter – Basis of accounting and restriction on distribution and use We draw attention to note 1 to the financial statements, which describes the basis of accounting. The financial statements are prepared in accordance with the financial reporting provisions of the IDA D1310 of the Project Financing Agreement. As a result, the financial statements may not be suitable for another purpose. Our report is intended solely for the West African Health Organisation and the World Bank and should not be distributed to or used by parties other than the West African Health Organisation and World Bank. Our opinion is not modified in respect of this matter. 13 INDEPENDENT AUDITOR’S REPORT TO THE MEMBERS OF PROJECT MANAGEMENT TEAM, WEST AFRICAN HEALTH ORGANISATION REPORT ON THE AUDIT OF THE FINANCIAL STATEMENTS (CONTINUED) Other Information The Project Management Team is responsible for the other information. The other information comprises the General Information and the Report of the Project Management Team but does not include the financial statements and our auditor’s report thereon. Our opinion on the financial statements does not cover the other information and we do not express any form of assurance conclusion thereon. In connection with our audit of the financial statements, our responsibility is to read the other information identified above and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit, or otherwise appears to be materially misstated. If, based on the work we have performed on the other information, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard. Responsibilities of management and those charged with governance for the financial statements Management is responsible for the preparation of the financial statements in accordance with the financial reporting provisions of IDA 1310 of the Project’s Financing Agreement and for such internal control as management determines is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. In preparing the financial statements, management is responsible for assessing the Project’s ability to continue as a going concern. Under the terms of the financing agreement the project will end on 31 August 2023. Those charged with governance are responsible for overseeing the Project’s financial reporting process. Auditor’s responsibilities for the audit of the financial statements Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements. As part of an audit in accordance with ISAs, we exercise professional judgement and maintain professional scepticism throughout the audit. We also: 14 INDEPENDENT AUDITOR’S REPORT TO THE MEMBERS OF PROJECT MANAGEMENT TEAM, WEST AFRICAN HEALTH ORGANISATION REPORT ON THE AUDIT OF THE FINANCIAL STATEMENTS (CONTINUED) Auditor’s responsibilities for the audit of the financial statements (continued) • Identify and assess the risks of material misstatement of the financial statements, whether due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control; • Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Project’s internal control; • Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and related disclosures made by management; and • Conclude on the appropriateness of management’s use of the going concern basis of accounting and, based on the audit evidence obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on the Project’s ability to continue as a going concern. If we conclude that a material uncertainty exists, we are required to draw attention in our auditor’s report to the related disclosures in the financial statements or, if such disclosures are inadequate, to modify our opinion. Our conclusions are based on the audit evidence obtained up to the date of our auditor’s report. However, future events or conditions may cause the Project’s to cease to continue as a going concern. We communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit and significant audit findings, including any significant deficiencies in internal control that we identify during our audit. The engagement partner on the audit resulting in this independent auditor’s report is Maxwell Darkwa ((ICAG/P/1143). PricewaterhouseCoopers (ICAG/F/2023/028) Chartered Accountants Accra, Ghana 19 June 2023 15 West African Health Organization (WAHO) The Regional Disease Surveillance Systems Enhancement (REDISSE) in West Africa Project Financial Statements For the year ended 31 December 2022 DESIGNA TED ACCOUNT STATEMENT FOR THE YEAR ENDED 31 DECEMBER 2022 (Ali amounts are expressed in US dollars unless otherwise stated) 2022 OOAS PROJET REDISSEI Financing Agreement IDA 01310 170040359017 US$ Balance as at 1 January 2022 640,242 Receipts from World Bank 1,524,854 Receipts from prefinancing other projects 741 Total funds available in the designated accounts 2.165.837 Movement: Eligible expenses paid during the year (2,050,672) Refund of wrong credit into project's bank account (5,840) Total payments (2,056,512) Balance at 31 December 2022 109,325 Add: Prefinance from WAHO 164,281 Actual Cash/bank balance as at 31 December 2022 273.606 The notes on page 17 are an integral part of these financial statements. The Designated Account tatement on pages 16 and 17 were approved by the Project Management Team on "" June 2023 and signed on its behalf by: Director Ge 16 West African Health Organization (WAHO) The Regional Disease Surveillance Systems Enhancement (REDISSE) In West Africa Project Financial Statements For the year ended 31 December 2022 NOTES 1. Accounting policies The following are the significant accounting policies adopted in the preparation of the designated account statement: (a) Basis of accounting The Designated Account Statement has been prepared in accordance with the provisions of the financing agreement IDA D1310. (b) Opening balance This amount represents prior year closing balances brought forward. (c) Transfer from IDA This represents transfers from the World Bank. Transfers are recognised as income when it hits the designated accounts. (d) Eligible expenditure This is made up all eligible payments made by the project during the period under review. 17 Annex 1 – RECONCILIATION OF AMOUNT RECEIVED BY REDISSE AND AMOUNT DISBURSED BY WORLD BANK Disbursement Amount Received by Amount disbursed by method Receiving Agency Date REDISSE World Bank Difference USD USD 27 WAHO REDISSE 27-Jan-22 360,327 360,327 - Transfers from World Bank to 28 WAHO REDISSE 15-Mar-22 545,446 545,446 - REDISSE designated account 29 WAHO REDISSE 07-Jul-22 449,719 449,719 - 30 WAHO REDISSE 25-Oct-22 169,362 169,362 - Total 1,524,854 1,524,854 - Direct payment to PD SM 04 14-Oct-22 1,221,439 1,221,439 - implementing PD FMX 04 BIS 14-Oct-22 676,167 676,167 - partners PD OIE 03 18-Feb-22 312,540 312,540 - Total 2,210,146 2,210,146 - Total disbursements 3,735,000 3,735,000 - Annex 2 – Schedule of Fixed Assets Register SUMMARY OF ADDITIONS TO FIXED ASSETS FOR THE YEAR ENDED 31 DECEMBER 2022 ASSETS Purchase date Location Amount (XOF) Motor vehicle Toyota Land Cruiser PRADO 4*4 - Station wagon - BVA 01/05/2018 WAHO 30,500,000